arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 11/2017 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    NEW ON THE MARKET

    First dimethyl fumarate single-drug preparation (SKILARENCE) for psoriasis

    Sarilumab (KEVZARA) against rheumatoid arthritis

    a-t READER´S QUESTIONS AND COMMENTS

    Do preservatives in nose drops damage cilia?

    Is the mucolytic agent tyloxapol (TACHOLIQUIN) beneficial?

    Teriparatide (FORSTEO) against osteoporosis: what is new?

    IN BRIEF

    Again: surrogate endpoints in oncology

    Europe and USA: mutual recognition of inspections of foreign companies

    CURRENT ADR NETWORK REPORT

    Hallucinations with lamotrigine (e.g. LAMICTAL)

    SIDE EFFECTS

    Do not use NSAIDs during the last trimester of pregnancy

    Further restrictions in the use of the multiple sclerosis drug daclizumab (ZINBRYTA)
    free

    Following unsuccessful measures of risk prevention: hydroxyethyl starch and flupirtine again under review

    e a-t ON THE INTERNET

    Tobacco company Philip Morris finances Foundation for a Smoke-Free World

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles